{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.3:c.88G>C",
          "cDNA Change": {
            "transcript": "NM_000345.3",
            "ref": "G",
            "alt": "C",
            "position": "88"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "A30P mutation"
        },
        {
          "HGVS": "NM_000345.3:c.157G>A",
          "cDNA Change": {
            "transcript": "NM_000345.3",
            "ref": "G",
            "alt": "A",
            "position": "157"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T mutation"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005180"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "M17 neuroblastoma cells",
        "Description": "Human neuroblastoma M17 cells were used for the experiments."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.3:c.88G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "resistance to proteosomal degradation",
          "Result Description": "A30P mutation displayed remarkable resistance to HO-1-induced proteosomal degradation."
        },
        {
          "Variant": "NM_000345.3:c.157G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "No significant effect",
          "Result Description": "A53T mutation did not affect a-synuclein degradation significantly in HO-1 over-expressing cells."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Experiments were performed in biological replicates."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type a-synuclein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression greater than 80% of control levels.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression less than 50% of control levels.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}